High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$200K
$200,749
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CTNM
S
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-03-02
$62,585
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-03-02 | $62,585 | S | Form 4 |
|
CTNM
M
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
Other
2026-02-25
$3,862
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-25 | $3,862 | M | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-25
$61,228
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-25 | $61,228 | S | Form 4 |
|
CTNM
M
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
Other
2026-02-24
$4,343
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-24 | $4,343 | M | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-24
$68,936
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-24 | $68,936 | S | Form 4 |
|
CTNM
M
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
Other
2026-02-19
$101
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-19 | $101 | M | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-19
$1,600
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-19 | $1,600 | S | Form 4 |
|
CTNM
M
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
Other
2026-02-11
$404
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-11 | $404 | M | Form 4 |
|
CTNM
S
Contineum Therapeutics, Inc.
Lorrain Daniel S.
• Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-11
$6,400
|
||||||
| CTNM |
Contineum Therapeutics, Inc.
|
Officer • Chief Scientific Officer
10b5-1 Sell
|
2026-02-11 | $6,400 | S | Form 4 |